Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
40 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Medicago Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Medicago Inc. - Product Pipeline Review - 2014', provides an overview of the Medicago Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Medicago Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Medicago Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Medicago Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Medicago Inc.'s pipeline products Reasons to buy - Evaluate Medicago Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Medicago Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Medicago Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Medicago Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medicago Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Medicago Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Medicago Inc. Snapshot 5 Medicago Inc. Overview 5 Key Information 5 Key Facts 5 Medicago Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Medicago Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Medicago Inc. - Pipeline Products Glance 12 Medicago Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Medicago Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Medicago Inc. - Drug Profiles 16 influenza [H1N1] (quadrivalent) (virus like particle) vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 influenza [H5N1] (virus like particle) vaccine + Glucopyranosyl Lipid A Adjuvant 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 influezna [H5N1] (virus like particles) vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 influenza [H7N9] (virus like particles) vaccine 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Biosimilar for Infectious Diseases 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 influenza (virus like particles) vaccine 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 influenza [H7N9] (virus like particle) vaccine + Glucopyranosyl Lipid A Adjuvant 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 rabies (virus like particles) vaccine 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 rotavirus (virus like particles) vaccine 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 VLP Vaccine 1 for Infectious Diseases 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 ebola (virus like particles) vaccine 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 VLP Vaccine 2 for Infectious Diseases 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Medicago Inc. - Pipeline Analysis 31 Medicago Inc. - Pipeline Products by Route of Administration 31 Medicago Inc. - Pipeline Products by Molecule Type 32 Medicago Inc. - Recent Pipeline Updates 33 Medicago Inc. - Locations And Subsidiaries 38 Head Office 38 Other Locations & Subsidiaries 38 Appendix 39 Methodology 39 Coverage 39 Secondary Research 39 Primary Research 39 Expert Panel Validation 39 Contact Us 40 Disclaimer 40
List of Tables Medicago Inc., Key Information 5 Medicago Inc., Key Facts 5 Medicago Inc. - Pipeline by Indication, 2014 8 Medicago Inc. - Pipeline by Stage of Development, 2014 9 Medicago Inc. - Monotherapy Products in Pipeline, 2014 10 Medicago Inc. - Combination Treatment Modalities in Pipeline, 2014 11 Medicago Inc. - Phase II, 2014 12 Medicago Inc. - Phase I, 2014 13 Medicago Inc. - Preclinical, 2014 14 Medicago Inc. - Discovery, 2014 15 Medicago Inc. - Pipeline by Route of Administration, 2014 31 Medicago Inc. - Pipeline by Molecule Type, 2014 32 Medicago Inc. - Recent Pipeline Updates, 2014 33 Medicago Inc., Other Locations 38 Medicago Inc., Subsidiaries 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.